Related Experiment Videos
Testosterone replacement treatment options for HIV-infected men
J Cofrancesco1, J J Whalen, A S Dobs
1Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Summary
Hypogonadism in men with HIV is common, especially with AIDS. Testosterone replacement may improve sexual function, energy, mood, and body mass, but requires further study in this population.
Area of Science:
- Endocrinology
- Infectious Diseases
- Men's Health
Background:
- Hypogonadism is frequently observed in men with HIV/AIDS, often associated with wasting syndrome.
- Testosterone deficiency diagnosis is achievable through basic laboratory tests.
- Established benefits of androgen replacement exist for hypogonadal men without HIV.
Purpose of the Study:
- To review the diagnosis and treatment of hypogonadism in HIV-infected men.
- To discuss the potential benefits and uncertainties of testosterone replacement therapy (TRT) in this specific population.
Main Methods:
- Literature review of hypogonadism in HIV-infected men.
- Discussion of diagnostic criteria and clinical suspicion.
- Overview of available testosterone replacement options (injections, transdermal patches).
Main Results:
- TRT in hypogonadal men generally improves sexual function, energy levels, mood, and quality of life.
- Testosterone replacement can maintain or increase lean body mass.
- The specific benefits, optimal dosage, and timing of TRT for men with HIV require additional research.
Conclusions:
- Hypogonadism in HIV-infected men can be diagnosed using clinical assessment and laboratory tests.
- While TRT offers potential benefits, its efficacy and safety in HIV-infected men need further investigation.
- Pharmacologic doses of testosterone are considered for potential anabolic effects.